Coronavirus disease 2019, COVID-19, has recently gained global proportions ([@r1]--[@r3]). This short report illustrates the use of voxel-level deep learning--based CT segmentation of pulmonary opacities ([@r4]) for improving quantification of the disease. A separate set of CT images from 10 cases of COVID-19 confirmed by real-time reverse transcriptase polymerase chain reaction test results was selected for training purposes. Expert manual segmentation of the lungs and pulmonary opacities was used as reference. A convolutional neural network based on U-Net architecture ([@r5]) was developed to predict the expert segmentation. We used this pipeline to analyze the contrasting evolution of two confirmed cases of COVID-19 from Wuhan, China, that were receiving similar supportive therapy. [Figure 1](#fig1){ref-type="fig"} shows the favorable evolution of a 48-year-old woman imaged at four time points across an interval of 16 days, while [Figure 2](#fig2){ref-type="fig"} shows the case of a 44-year-old man with disease progression over 12 days, especially between the second and third studies. These examples illustrate the potential of deep learning--based quantitative CT for providing objective assessment of pulmonary involvement and therapy response in COVID-19, but further studies are still necessary to determine the performance of such an approach in this scenario.

![Evolution of COVID-19 in a 48-year-old woman across 16 days of treatment. *A,* Axial unenhanced chest CT images at four time points (dates annotated in each panel) show peripheral ground-glass opacities and consolidation. *B,* Color overlay of voxel-level segmentation at the same level and time points as in *A* show pulmonary opacities displayed in yellow and normal lung in blue. *C,* Coronal reconstructions at the same time points as in *A* show progressive improvement of the lung opacities. *D,* Three-dimensional volume-rendered reconstructions at the same time points as in *A* show pulmonary opacities displayed in yellow, normal lung and vessels in light gray, and tracheobronchial tree in green. The volumetric assessment of the pulmonary opacities derived from the deep learning--based quantitative CT analysis is annotated at different time points on the volume-rendered images. LOV = lung opacification volume.](ryct.2020200082.fig1){#fig1}

![Evolution of COVID-19 in a 44-year-old man across 12 days of treatment. *A,* Axial unenhanced chest CT images at four time points (dates annotated in each panel) show a small nodular opacity in the right upper lobe on the initial CT, progressing to a larger area of ground-glass opacity and consolidation, especially at time points 2 and 3. *B,* Color overlay of voxel-level segmentation at the same level and time points as in *A* show pulmonary opacities displayed in yellow and normal lung in blue. *C,* Coronal reconstructions at the same time points as in *A* show progression of the lung opacities, especially across first and third time points. *D,* Three-dimensional volume-rendered reconstructions at the same time points as in *A* show pulmonary opacities displayed in yellow, normal lung and vessels in light gray, and tracheobronchial tree in green. The volumetric assessment of the pulmonary opacities derived from the deep learning--based quantitative CT analysis is annotated at different time points on the volume-rendered images. LOV = lung opacification volume.](ryct.2020200082.fig2){#fig2}
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